← SynDRA
(S)APOMORPHINE
SynDRA canonical compound SYN0002503 — structure-anchored drug synonym record
| Primary target(s) | TRPA1 |
|---|
| Mechanism of action | Dopamine receptor agonist |
|---|
All known targets
- DRD1
- DRD2
- ADRA2A
- ADRA2B
- ADRA2C
- DRD3
- DRD4
- DRD5
- HTR1A
- HTR2A
- HTR2B
- HTR2C
Mechanisms of action (all sources)
- Dopamine receptor agonist
- DRD1 INHIBITOR
- DRD2 INHIBITOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- MDM2
- DAB2IP
- ALDH1A1
- MPI
- IDH1
- KDM4A
- KDM4E
- LMNA
- MAPK1
- MAPT
- MCL1
- NFKB1
- HSD17B10
- PABPC1
- PKM
- PLK1
- POLB
- POLI
- SMAD3
- TDP1
- THPO
- TP53
- HTT
- HPGD
- ALOX12
- CYP2C9
- ALOX15
- ALOX15B
- ATXN2
- BAZ2B
- CBX1
- CTSL
- CYP1A2
- CYP2C19
- CYP2D6
- HIF1A
- CYP3A4
- EHMT2
- FEN1
- G6PD
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ABC3G
- ABL1
- RUNX1
- RIN1
- PIP4K2A
- PHGDH
- PEBB
- PABP1
- NLRP1
- MLLT3
- LYAG
- IDHC
- GSTO1
- GEMI
- DLD
- DAB2
- CP1A2
- CASP1
- BCL2
- B2LA1
- B2CL2
- B2CL1
- APAF
- TPO
Cross-references
Synonyms
- S-(+)-apomorphine
- S-apomorphine
- UNII-LH812IV7LI
- LH812IV7LI
- CHEMBL416288
- (6aS)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol
- 4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (S)-
- S(+)-APOMORPHINE
- (+)-10,11-Dihydroxyaporphine
- Apomorphine, S-
- AC1LEHBI
- Lopac-A-4393
- Oprea1_044402
- SCHEMBL6922802
- GTPL8285
- CTK1C3986
- cid_6852389
- BDBM29643
- DTXSID40192615
- MolPort-002-507-063
- (6as)-10,11-dihydroxyaporphine
- ZINC155525
- PDSP1_001504
- apomorphine
- S-(+)-Apomorphine
- RefChem:1098203
- (+)-Apomorphine
- S(+)-10,11-DIHYDROXYAPORPHINE HYDROCHLORIDE
- Apomorphine,(+)
- APOMORPHINE, (S)-
- SCHEMBL30554804
- PDSP2_000768
- AKOS004119832
- HY-136840A
- NCGC00015057-01
- NCGC00142462-01
- S(+)-apomorphine
- SCHEMBL19469972
- Opera_ID_220
Look up (S)APOMORPHINE in the interactive SynDRA portal →